Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins
- PMID: 10762016
Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins
Abstract
Progression of tumor cells toward a high malignancy phenotype and metastasis is a multi-event cascade involving inter alia alterations in the expression of various genes. The focus of our laboratory is on genes whose altered expression may lead, directly or indirectly, to an increased malignancy phenotype. The identification of such genes and the evaluation of the consequences of their altered expression is essential for attempts to halt tumor progression and prevent metastasis formation. Published work originating in our laboratory showed that members of the murine Ly-6 supergene family are involved in the progression of certain mouse tumors. The expression level of several members of this family was higher on highly malignant cells than on tumor cells expressing a lower malignancy phenotype. Sorting by flow cytometry of tumor cells to subpopulations expressing either high or low levels of Ly-6E.1 yielded correspondingly cells expressing a high or a low malignancy phenotype. The high malignancy, high Ly-6E.1-expressing cells also expressed high levels of the receptor for urokinase plasminogen activator (uPAR), whereas low malignancy, low Ly-6E.1-expressing cells also expressed low levels of uPAR. Transfection studies indicated that uPAR was causally involved in conferring a high malignancy phenotype upon tumor cells expressing high levels of Ly-6E.1. E48 is a human homologue of the murine ThB protein, a member of the Ly-6 supergene family (but distinct from the Ly-6E.1 protein mentioned above) and expressed on head and neck squamous carcinoma cells. Experiments currently in progress are aimed to find out whether E48 is involved in the progression of such cancer cells. Using the differential display technology, it was shown that ligation of E48 on tumor cells by the corresponding antibodies (serving as a surrogate for an as yet unidentified E48 ligand) upregulates an enzyme (FX) involved in the biosynthesis of GDP-L-fucose. Fucose is an essential component of certain selectin ligands.
Similar articles
-
A gain of novel tissue specificity in the human Ly-6 gene E48.J Immunol. 1997 Nov 15;159(10):4879-86. J Immunol. 1997. PMID: 9366413
-
Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.Cancer Res. 2004 Sep 15;64(18):6571-8. doi: 10.1158/0008-5472.CAN-03-4038. Cancer Res. 2004. PMID: 15374970
-
The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.J Biol Chem. 2000 Apr 28;275(17):12833-40. doi: 10.1074/jbc.275.17.12833. J Biol Chem. 2000. PMID: 10777581
-
The plasminogen activator inhibitor "paradox" in cancer.Immunol Lett. 2008 Jun 30;118(2):116-24. doi: 10.1016/j.imlet.2008.03.017. Epub 2008 May 2. Immunol Lett. 2008. PMID: 18495253 Review.
-
Mouse Ly-6 proteins and their extended family: markers of cell differentiation and regulators of cell signaling.Arch Immunol Ther Exp (Warsz). 2004 Jul-Aug;52(4):255-66. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15467490 Review.
Cited by
-
Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration.PLoS One. 2011;6(11):e27841. doi: 10.1371/journal.pone.0027841. Epub 2011 Nov 29. PLoS One. 2011. PMID: 22140470 Free PMC article.
-
Proteases and glioma angiogenesis.Brain Pathol. 2005 Oct;15(4):327-41. doi: 10.1111/j.1750-3639.2005.tb00118.x. Brain Pathol. 2005. PMID: 16389945 Free PMC article. Review.
-
Nonadherent culture method downregulates stem cell antigen-1 expression in mouse bone marrow mesenchymal stem cells.Exp Ther Med. 2015 Jul;10(1):31-36. doi: 10.3892/etm.2015.2457. Epub 2015 Apr 29. Exp Ther Med. 2015. PMID: 26170908 Free PMC article.
-
SDF1/CXCL12 is involved in recruitment of stem-like progenitor cells to orthotopic murine malignant mesothelioma spheroids.Anticancer Res. 2010 Jun;30(6):2153-60. Anticancer Res. 2010. PMID: 20651364 Free PMC article.
-
Significance of PSCA as a novel prognostic marker and therapeutic target for cancer.Cancer Cell Int. 2024 Apr 16;24(1):135. doi: 10.1186/s12935-024-03320-6. Cancer Cell Int. 2024. PMID: 38627732 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials